Several multiple comparison procedures (MCPs) are discussed in relation to the specific formulation oftype I and type I errors in toxicity studies and the typical one-way design control versus k treatment/dose groups. Examples ofthese MCPs are: the standard many-to-one MCP (Dunnett's procedure), sequential rejection modifications, closedtesting procedures, many-to-one MCPs with an ordered alternative hypotheis, procedures based on the assumption ofa mixing distribution of responders and nonresponders, and MCP's for multiple end points.
Introduction
Why is it that multiple comparison procedures (MCPs) are being discussed in toxicology even today, despite the fact that they are every-day procedures in biostatistics? This paper deals with several sources ofmultiplicity in long-term toxicity studies and possible methods for suitable statistical analysis.
Based on the closed testing principle discussed by Marcus et al. (1) , a revolution in MCPs has taken place. We can thus diminish the antagonism enforcing aexp (type I error) and decreasing the power r (where ir = 1 -3, ... type II error). This paper presents a special case where as is held and the maximum power of the two-sample case is guaranteed. This paper is therefore limited to regulatory toxicity studies, e.g., carcinogenicity, mutagenicity, according to national/international guidelines, for example, the European Community (EC) guideline (2) . Regulatory toxicity studies are so-called safety studies, the purpose of which is to ascertain carcinogenic, mutagenic side effects etc. For this purpose, the statistical hypothesis in relation to type I and II errors should be specified: a) The risk of a type I error, a, represents the producer's risk: the conclusion is therefore that a toxic side effect exists, while in fact this is not the case. b) The riskofatype I error, (3, represents the customer's risk: the conclusion is therefore that a toxic effect does not exist, while in truth one actually does. Intuitively, it is clear that both risks must be handled with care, even though controlling the type II error should be of primary concern in toxicology.
Usually n. = Vknj (14) (15) (16) . This is not the case for the Williams (17) procedure, assuming an ordered alternative (18) . The power depends on the number oftreatment or dose groups k, which implies that inclusion of further nonsignificant treatment groups can lead to overlooking significant effects (19) . A rule for design using MCPs is to use only the minimal necessary number of treatment/dose groups.
In the case ofvariance heterogenicity, Dunnett's procedure is not robust (12) . Other approaches should be used in this case, e.g., e-adjusted Welch-tests or Brownie (20) type of control group variance inclusion (Hothorn and Ortseifen, in preparation).
Simultaneous versus Sequential Rejective Procedures
The closed testing principle in many-to-one MCPs is quite simple (in comparison with all-pair MCPs) because a complete system ofhypotheses with (2k -1) elementary hypotheses (21) is given. Several types ofsequential rejective modifications will be discussed: a) Bonferroni/Holn (22) Fpatho(x) = Fc(x- 6) according to Good (41) and power:
Fpatho(X) = Fa(X) according to Lehmann (40) . Johnson et al. (42) suggested, for the shift alternative, approximate score statistics based on following mixed normal score function:
where i is a rank in the combined (control+treatment) sample, d is a constant (in the simulation study where d=0.5,1,1.5,2 were used; only the case d=l will be reported here), and 4-' is a distribution function of the normal distribution.
As a generalization of Wilcoxon-Mann-Whitney (WMW) scores, Conover and Salsburg (43) proposed the following approximate score function for the power alternative:
where a is an integer constant (a=3,4,5,6 were used in the simulation study; here, only the case a=4 will be reported).
In toxicology, tests based on this mixing distribution assumption were used for behavioral studies (44) , teratological studies (45) , sister chromatid exchange mutagenicity assays (42) , chronic studies (5), and micronucleus mutagenicity assays (46) . With simulation studies (42, 46) The multivariate problem also consists of a complete hypothesis system of 2k -1 elementary hypotheses (21) . The decision scheme is quite simple (51), as can be seen for the four end points in Figure 2 . Based on the level a-test on each step, this procedure shows good power behavior. This procedure is available as a PC program for up to 10 end points (Hothorn and Nagel, submitted).
An interesting extension ofthis method is possible for toxicity studies with both multiple end points and multiple treatment or dose groups based on the closed testing procedure under the assumption ofan ordered alternative using Williams (17) MCP. With this approach, decisions can be performed both on the multiple end points and the multiple dose group based on level a tests on each step, but holding ac,,p (50) .
Summary
This paper reveals several sources of multiplicity within longterm toxicity studies and their suitable treatment, the possibility of reducing the antagonism between holding asp and ensuring the maximum power, that special MCPs for biostatistical analysis of long-term toxicological studies are necessary and are available as a PC program.
